U.S. markets open in 8 hours 59 minutes
  • S&P Futures

    4,128.25
    +4.75 (+0.12%)
     
  • Dow Futures

    33,948.00
    +14.00 (+0.04%)
     
  • Nasdaq Futures

    12,536.50
    +21.00 (+0.17%)
     
  • Russell 2000 Futures

    1,967.50
    +2.40 (+0.12%)
     
  • Crude Oil

    74.94
    +0.83 (+1.12%)
     
  • Gold

    1,886.70
    +7.20 (+0.38%)
     
  • Silver

    22.36
    +0.12 (+0.55%)
     
  • EUR/USD

    1.0741
    +0.0010 (+0.10%)
     
  • 10-Yr Bond

    3.6340
    -3.5320 (-100.00%)
     
  • Vix

    19.43
    -18.33 (-100.00%)
     
  • GBP/USD

    1.2048
    +0.0024 (+0.20%)
     
  • USD/JPY

    132.2970
    -0.3100 (-0.23%)
     
  • BTC-USD

    22,914.27
    +124.38 (+0.55%)
     
  • CMC Crypto 200

    526.25
    +1.11 (+0.21%)
     
  • FTSE 100

    7,836.71
    -65.09 (-0.82%)
     
  • Nikkei 225

    27,678.37
    -15.28 (-0.06%)
     

Quotient Second Quarter 2023 Earnings: Revenues Miss Expectations

Quotient (NASDAQ:QTNT) Second Quarter 2023 Results

Key Financial Results

  • Revenue: US$8.86m (down 6.5% from 2Q 2022).

  • Net loss: US$45.9m (loss widened by 69% from 2Q 2022).

earnings-and-revenue-history
earnings-and-revenue-history

All figures shown in the chart above are for the trailing 12 month (TTM) period

Quotient Revenues Disappoint

Revenue missed analyst estimates by 10%.

Looking ahead, revenue is forecast to grow 39% p.a. on average during the next 3 years, compared to a 7.4% growth forecast for the Medical Equipment industry in the US.

Performance of the American Medical Equipment industry.

The company's shares are down 14% from a week ago.

Risk Analysis

It is worth noting though that we have found 6 warning signs for Quotient (4 make us uncomfortable!) that you need to take into consideration.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here